MEI Pharma acquires ~$110M in Litecoin, becomes first US-listed company to adopt LTC as primary reserve

Lite Strategy, Inc.

Acquired 929,548 LTC tokens at avg price $107.58; LTC treasury valued at ~$110.4M as of Aug 4, 2025.
Deployed all net proceeds from July 17, 2025 PIPE Offering with Titan Partners as placement agent.
Strategy developed with GSR; Litecoin creator Charlie Lee (MEI board member) providing guidance.
Company plans to update corporate identity and may start Litecoin mining; continues pre-clinical drug pipeline voruciclib.
First US-listed public company to adopt Litecoin as primary reserve asset for treasury strategy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.